Journal of Neuroscience and Clinical Neurology

Lucienne Costa Frossard Franca

MD

  • Department: Neurology
  • University: Universidad Francisco de Vitoria
  • Country: Spain

Dr. Lucienne Costa-Frossard França, MD, is a Consultant Neurologist at the National Multiple Sclerosis (MS) Reference Center of the Hospital Universitario Ramón y Cajal in Madrid, Spain, and a researcher at the Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS). She holds a Medical Degree (Licenciatura en Medicina y Cirugía) from the Universidad de Barbacena (Brazil, 1995), where she graduated with distinction (Premio José Bonifacio de Andrade), and completed her Specialization in Neurology at the Hospital Universitario Ramón y Cajal (Spain, 2006). Dr. Costa-Frossard is an established clinician-scientist with a dual profile in clinical neurology and translational neuroimmunology research, focusing on Multiple Sclerosis (MS). She has extensive experience in clinical trial coordination, having served as principal investigator and national coordinator for numerous multicenter trials in Spain on advanced MS treatments, including anti-CD20 therapies (ocrelizumab, ofatumumab, rituximab), S1P modulators, BTK inhibitors, extended-interval natalizumab, and CAR-T cell therapy approaches.

Clinical and Research Positions

  • Consultant Neurologist, National MS Reference Center, Hospital Universitario Ramón y Cajal (since 2009)

  • Researcher, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS)

  • Member, Red Española de Esclerosis Múltiple (REEM)

  • Advisor, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

University Teaching and Coordination

  • Director & Coordinator, Master’s in Clinical Management of an MS Unit – Universidad Francisco de Vitoria

  • Coordinator, University Certificate in Differential Diagnosis in MS – Universidad Francisco de Vitoria

  • Professor, Master’s in Multiple Sclerosis – Universidad Francisco de Vitoria

  • Lecturer, Course in Neuroimmunology and MS – Universidad Autónoma de Madrid

  • Coordinator, Course on Demyelinating Diseases for Neurology Residents – Asociación Madrileña de Neurología

Editorial & Professional Engagements

  • Editorial Board Member, Iberoamerimed (Spain, Portugal, and Latin America)

  • Scientific Committee Member, MS-related national training and consensus programs

Research Projects and Collaborations

  • Participant in Spanish MS Network projects (REEM, RD17/0015/0001) and national I+D+i funded studies.

  • Co-author of over 60 peer-reviewed scientific papers in high-impact journals such as Frontiers in Immunology, Multiple Sclerosis Journal, and JAMA Neurology.

Publications and Books

  • Author and co-author of several MS-focused medical texts, including:

    • Gestión Clínica en Unidades de Esclerosis Múltiple (3 volumes)

    • Importancia de la Vitamina D en los pacientes con Esclerosis Múltiple

    • Planificación Familiar y Esclerosis Múltiple: 100 respuestas clave

    • Libro Blanco de la Esclerosis Múltiple en España (2020)

  • Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases
  • Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis
  • Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis
  • Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
  • Economic burden of secondary progressive multiple sclerosis: DISCOVER study
  • Predictive Value of the Combination of CSF and Serum Biomarkers at Disease Onset in Multiple Sclerosis (S33.007)
  • Short‐chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile
  • Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients